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Phosphatidylserine exposure occurs in red blood cells (RBCs) from sickle cell disease (SCD) patients and is increased by deoxygena-
tion. The mechanisms responsible remain unclear. RBCs from SCD patients also have elevated cation permeability, and, in partic-
ular, a deoxygenation-induced cation conductance which mediates Ca2+ entry, providing an obvious link with phosphatidylserine
exposure. The role of Ca2+ was investigated using FITC-labelled annexin. Results confirmed high phosphatidylserine exposure in
RBCs from SCD patients increasing upon deoxygenation. When deoxygenated, phosphatidylserine exposure was further elevated
as extracellular [Ca2+] was increased. This eﬀect was inhibited by dipyridamole, intracellular Ca2+ chelation, and Gardos channel
inhibition. Phosphatidylserine exposure was reduced in high K+ saline. Ca2+ levels required to elicit phosphatidylserine exposure
were in the low micromolar range. Findings are consistent with Ca2+ entry through the deoxygenation-induced pathway (Psickle),
activating the Gardos channel. [Ca2+] required for phosphatidylserine scrambling are in the range achievable in vivo.
1. Introduction
Patients with sickle cell disease (SCD) display a range of
symptoms which include chronic anemia together with
ischemic pain and organ damage [1]. The underlying cause
is the presence in patients’ red blood cells (RBCs) of the
abnormal hemoglobin, HbS [2]. HbS polymerises into rigid
rods on deoxygenation, changing RBC shape from biconcave
disc into the characteristic sickle appearance [3]. RBC mem-
brane permeability is markedly abnormal [4] whilst HbS is
also unstable, representing an oxidative threat [5]. Altered
behaviour of these HbS-containing RBCs (here termed
HbS cells), other circulating cells, and the endothelium
combine to reduce RBC lifespan (hence the anemia) and
also result in microvascular occlusion (hence the ischemia)
[6]. Although the exact pathogenesis remains unclear, an
important feature is considered to be increased exposure
of phosphatidylserine (PS) on the outer bilayer of the RBC
membrane [7–10]. Externalised PS is prothrombotic, and
also provides a potential adhesion site for both macrophages
and activated endothelial cells, contributing to both reduced
HbS cell lifespan and vascular occlusion [11–13].
Two membrane phospholipid transporters represent the
major determinants of PS exposure in RBCs: the ATP-
dependent aminophospholipid translocase (APLT or flip-
pase) transports aminophospholipids (APs), including PS,
from outer to inner leaflet, whilst the Ca2+-dependent scram-
blase moves APs rapidly in both directions thus disrupting
phospholipid asymmetry [14]. In normal RBCs, PS is largely
confined to inner leaflet, through the dominant action of the
flippase whilst the scramblase remains quiescent. A small, but
variable, proportion of HbS cells from sickle cell patients,
however, show exposure of PS ranging from about 2–10%
[7, 9, 15, 16]. Both flippase inhibition and activation of the
scramblase are probably involved [17]. Flippase inhibition
could follow oxidative stress [18, 19], whilst scramblase
activation could be caused by raised intracellular Ca2+ (e.g.,
[19, 20]) or other stimuli (e.g., [21]). The exact mechanisms,
however, remain uncertain.
It is also well established that deoxygenation of HbS in
vitro results in increased PS exposure [22, 23] but, again, the
mechanism is not clear. Possibilities include disruption of the
spectrin cytoskeleton [24], ATP depletion [25], decrease in
intracellular Mg2+ [26], and also a rise in intracellular Ca2+
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[20, 26]. In many reports concerning PS exposure, however,
Ca2+ is not controlled or is present at unphysiological
levels, making it diﬃcult to assess its role definitively. In
addition, whilst a more recent study correlated PS exposure
in HbS cells with flippase inhibition, rather than elevation
of intracellular Ca2+, the eﬀects of deoxygenation were not
determined [9].
Deoxygenation of HbS cells as well as causing HbS
polymerisation and shape change, also activates a permeabil-
ity pathway termed Psickle [4, 27]. Psickle is often described
as a deoxygenation-induced cation conductance, apparently
unique to HbS-containing red cells. A major importance of
Psickle is its permeability to Ca
2+ [28, 29]. Although Ca2+
entry via this pathway represents an obvious link between
HbS polymerisation and the deoxygenation-induced PS
exposure, estimates suggest that the magnitude to which
Ca2+ may be elevated is still relatively modest (around
100 nM) [29], and several orders of magnitude below that
required for scramblase activation (around 100 μM is usually
cited [20, 30–32]). The present work is aimed at assessing the
role of Ca2+ in PS exposure in RBCs from sickle cell patients.
2. Materials and Methods
2.1. Blood. Anonymised, discarded, routine blood samples
(taken into the anticoagulant EDTA) were collected from
individuals homozygous for HbS (HbSS genotype, n =
62) with approval from the local Ethics committee. After
withdrawal, blood samples were kept refrigerated until used.
(RBCs from HbSS individuals are here termed HbS cells).
2.2. Salines and Chemicals. HbS cells were washed into
low (LK) or high potassium- (HK-) containing saline,
comprising (in mM) NaCl 140, KCl 4, glucose 5, HEPES 10
for LK saline, and NaCl 55, KCl 90, glucose 5 and HEPES 10
for HK saline, all pH 7.4 at 37◦C, with diﬀerent extracellular
[Ca2+]s ([Ca2+]os) as indicated. When required, inhibitors
(clotrimazole, DIDS, and dipyridamole) were added from
stock solutions in DMSO. In these experiments, DMSO
(final concentration 0.5%) was also added to controls. To
investigate the eﬀect of Ca2+ chelation, MAPTAM (5 μM;
Calbiochem, UK) was loaded into RBCs (5% haematocrit)
for 60 min at 37◦C with added pyruvate (5 mM) to pre-
vent inhibition of glycolysis [33]. Extracellular chelator
was removed by washing once with saline. Control RBCs
without chelator were handled in the same way. FITC-
labelled annexin V was obtained from Becton-Dickinson
(Oxford, UK) in aqueous stock solutions (final concentration
0.3 μg·mL−1). The calmodulin inhibitor N-(6-aminohexyl)-
5-chloro-1-naphthalene sulphonamide (W-7) and the cal-
cium fluorophore fluo-4-AM came from Invitrogen; all other
reagents were obtained from Sigma (Poole, UK).
2.3. Control of O2 Tension, Measurement of PS Exposure
and Intracellular Ca2+. Salines and HbS cell suspensions
were first equilibrated with humidified air (oxygenated) or
N2 (deoxygenated) in Eschweiler tonometers (Eschweiler,
Kiel, Germany). They were then placed in 24-well plates
(108 cells·mL−1, depth 3 mm) at 37◦C in humidified incu-
bators flushed with room air or 1% O2 (using a Galaxy-R
oxygen incubator, RS Biotech, Irvine, UK) for 3–18 hours.
After incubation, RBCs were treated with vanadate (1 mM)
to inhibit flippase activity. They were then immediately har-
vested, washed once, and resuspended at a concentration of
5×106 cells·mL−1 in binding annexin buﬀer (composition in
mM: 145 NaCl, 2.5 CaCl2, 10 HEPES, pH 7.4) and incubated
for 15 min at room temperature with FITC-labelled annexin
(0.3 μg·mL−1). Unattached annexin was then removed by
washing once followed by resuspension in 5-times the initial
volume of ice-cold binding buﬀer, after which samples were
placed on ice. Percentage of RBCs with PS exposed on their
external membrane was then measured in the FL-1 channel
of a fluorescence-activated flow cytometer (FACSCalibur,
BD), in which negative fluorescent gate was set using cells
exposed to FITC-labelled annexin but in the absence of Ca2+
(which prevents annexin binding). PS exposure here refers
to the percentage of RBCs which fluoresce more brightly
than the negative gate. To alter intracellular [Ca2+], RBCs
at 1% Hct were exposed to the calcium ionophore bromo-
A23187 (1–6 μM), vanadate (1 mM), EDTA (2 mM), and
diﬀerent [Ca2+]os for 30 min to achieve the requisite final
[Ca2+]o [34]. This was multiplied by the square of Donnan
ratio, r2([H+]i/[H
+]o)
2 = 2.05 [35, 36], to calculate [Ca2+]i.
After 30 min, RBCs were treated with Co2+ (0.4 mM, to
block A23187) after which they were processed for annexin-
labelling, as above. Annexin was used to label PS because it is
important to compare findings with extensive reports in the
literature using this PS marker (e.g., [8, 19, 37–39]). Bromo-
A23187 (in preference to A23187 per se) was used because it
does not fluoresce. These experiments were carried out in LK
or HK saline, composition as above except for the addition of
0.15 mM MgCl2 to keep intracellular [Mg
2+] at physiological
levels. Finally, to show Ca2+-loading of RBCs, cells were
loaded with fluo-4-AM (30 min at 37◦C, 5 μM; then washed
once) with fluo-4 fluorescence also then measured in the
FITC channel by FACS.
2.4. Statistics. Unless otherwise stated, data are presented
as means ± S.E.M. for blood samples from n patients.
Statistical significance of any diﬀerences was tested using
paired Student’s t-test (with P < .05 taken as significant).
3. Results
3.1. The Eﬀect of Ca2+ on PS Exposure. PS exposure in
HbS cell samples taken from SCD patients and immediately
labelled with FITC-annexin ranged from 0.4 to 16.0% with a
mean of 2.3± 0.5% (n = 36). The eﬀect of diﬀerent [Ca2+]os
(0.1, 0.5, 1.1, 2 and 5 mM) on the percentage of HbS cells
showing PS exposure was then investigated. In oxygenated
(20% O2) HbS cells, PS exposure was lower and although
the extent of exposure was augmented when RBCs were
incubated at higher [Ca2+]os, the eﬀect was small and not
significant (Figure 1). When cells were deoxygenated (1%
O2), PS exposure was always higher than that observed in
oxygenated HbS cells. There was also a marked increase in
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Figure 1: Eﬀect of oxygen tension and extracellular Ca2+ on
phosphatidylserine (PS) exposure in red blood cells (RBCs) from
sickle cell patients. RBCs were incubated for 18 hours at four
extracellular [Ca2+]’s (0.5, 1.1, 2.0 and 5.0 mM) after which they
were labelled with FITC-annexin (as described in Section 2).
Histograms representing mean percentage of positive RBCs ±
S.E.M. for 5 diﬀerent patients. ∗P < .01 deoxy compare to oxy;
+P < .05 cf 0.5 mM Ca2+ deoxy; #P < .01 cf 0.5 mM Ca2+ deoxy.
PS at the higher [Ca2+]os (Figure 1). This eﬀect was present
within 30 min, with longer incubation periods increasing the
eﬀect. To determine whether Ca2+ was acting extracellularly
or intracellularly, HbS cells were loaded with the Ca2+
chelator MAPTAM prior to deoxygenation (Figure 2). Over
a 3 hour period, MAPTAM decreased the percentage of
positive HbS cells (P < .01). This inhibitory eﬀect did
not persist over an 18 hour incubation, probably because
the available cytoplasmic MAPTA becomes saturated with
Ca2+.
3.2. Eﬀect of Partial Psickle Inhibitors on PS Exposure.
Although there are no specific inhibitors of Psickle, dipyri-
damole is partially eﬀective [40]. When present during
deoxygenation, dipyridamole (50 μM) reduced PS exposure
in deoxygenated HbS cells (Figure 2; P < .01), consistent
with Ca2+ entry via Psickle stimulating exposure. DIDS,
although better known as a band 3 inhibitor, is also a
partial Psickle inhibitor [41]. Addition of DIDS (50 μM),
however, produced a marked increase in PS exposing RBCs
with percentage of positive RBCs increasing several folds
(Figure 2; P < .01). When DIDS was added to RBCs from
normal HbAA individuals, PS exposure was also similarly
increased: to 95.0 ± 0.3% in oxygenated conditions, and to
98.7±0.1% in deoxygenated cells (both means±S.E.M., n =
3). These findings suggest that annexin binding was caused
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Figure 2: Eﬀect of inhibitors on phosphatidylserine (PS) exposure
in red blood cells (RBCs) from sickle cell patients. RBCs were
incubated under deoxygenated conditions (1% O2) for 3 hours
(5 mM extracellular [Ca2+]) after which they were labelled with
FITC-annexin. Four conditions (all with 0.5% DMSO) are shown:
MAPTAM-treated RBCs (loaded with 5 μM MAPTAM prior to
deoxygenation), clotrimazole (10 μM), dipyridamole (50 μM), and
DIDS (50 μM). Results are presented as percentage PS exposing
RBCs relative to control RBCs exposed to 0.5% DMSO only.
Histograms represent means ± S.E.M. (n = 3). ∗P < .01 and
#P < .0001 cf DMSO controls.
by DIDS reacting with its target on the RBC membrane.
HbS cells exposed to DIDS, but not subsequently treated
with FITC-annexin, did not fluoresce (e.g., 0% DIDS-treated
without FITC-annexin cf 50% DIDS-treated with annexin),
indicating that the high values were not due to fluorescence
from DIDS itself.
3.3. PS Exposure and Red Cell Shrinkage. Elevated intracel-
lular Ca2+ activates the Gardos channel and leads to K+
loss with Cl− following through separate Cl− channels [4].
PS exposure could therefore be secondary to the ensuing
cell shrinkage [37]. To investigate this possibility, HbS cells
were suspended in high K+-containing saline (90 mM) to
remove any gradient for K+ eﬄux. The deoxygenation-
induced increase in PS exposure was abolished (Figure 3),
with values reduced to those observed in oxygenated samples
(P < .001 deoxy LK cf oxy LK; N.S. deoxy HK cf oxy LK).
An estimate of RBC size is provided by FACS forward scatter
measurement. Forward scatter was 487± 8 (means± S.E.M.,
n = 3) in oxygenated LK saline, falling to 439 ± 4 in
deoxygenated LK saline (P < .005). In deoxygenated HK
saline a value of 497 ± 3 was obtained (N.S. cf. oxygenated
LK saline). PS exposure following deoxygenation in LK saline
was therefore accompanied by cell shrinkage. This was not
observed during deoxygenation in high K+ saline. A second
method of inhibiting the Gardos channel, treatment with
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Figure 3: Eﬀect of extracellular K+ on phosphatidylserine (PS)
exposure in red blood cells (RBCs) from sickle cell patients. RBCs
were incubated for 18 hours with extracellular [Ca2+] of 5 mM
under oxygenated (20% O2) or deoxygenated (1% O2) conditions in
either low K+-containing (extracellular [K+] of 5 mM) saline or high
K+-containing (90 mM [K+]) saline. Histograms represent means±
S.E.M. (n = 3). ∗P < .001 compare to LK oxy; #N.S. cf. LK oxy.
clotrimazole (10 μM), was also tested. In this case, however,
PS exposure was only partially prevented (Figure 2; P < .01).
3.4. PS Exposure and Direct Manipulation of Intracellu-
lar [Ca2+]. Treatment of RBCs with the divalent cation
ionophore bromo-A23187 was used to alter intracellular
[Ca2+] directly [34, 35]. RBCs were initially treated with
vanadate (1 mM), to inhibit both the plasma membrane
Ca2+ pump and also the flippase. Following 30 min incu-
bation with bromo-A23187 to alter [Ca2+]i, Co
2+ (0.4 mM)
was then added to block Ca2+ permeability via A23187
thereby keeping intracellular [Ca2+] constant during annexin
labelling (for which 2.5 mM extracellular [Ca2+] is required).
Results are shown in Figure 4. PS exposure is elicited as
[Ca2+]i increased above about 600 nM. A sigmoidal depen-
dence of PS exposure with [Ca2+] was then apparent with
an EC50 of 1.31 ± 0.84 μM (n = 6). Peak exposures varied
from 16–46%, mean 28± 5 (n = 6) with a plateau reached at
about 10 μM and without further change at higher [Ca2+]is
([Ca2+]s up to 600 μM were tested).
3.5. Modulation of PS Exposure. In the preceding section,
although high aﬃnity Ca2+-induced scrambling was present,
it was noticeable that nevertheless only a minority of all
RBCs stained positively for PS using FITC-annexin—as is
also found in many literature reports, for example, [39].
That Ca2+ loading was complete and homogeneous was
first ascertained using intracellular fluo-4 (Figure 5). It
is apparent that the majority of RBCs (98 ± 1%, n = 3)
were Ca2+-loaded. Uneven Ca2+ loading can therefore be
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Figure 4: Eﬀect of manipulation of intracellular Ca2+ on phos-
phatidylserine (PS) exposure in red blood cells (RBCs) from sickle
cell patients. RBCs were first treated with vanadate (1 mM) to
inhibit the plasma membrane Ca2+ pump and also the aminophos-
pholipid translocase (flippase) before addition of bromo-A23187
(1.2 μM, 1% haematocrit) and requisite extracellular [Ca2+]s for
30 min. They were then treated with Co2+ (0.4 mM) before
labelling with FITC-annexin. Intracellular [Ca2+] is calculated from
extracellular [Ca2+] × r2, where r2 was taken as 2.05 [36]. Results
presented are from a single experiment representative of 5 others.
discounted. As K+ has been reported to inhibit PS scrambling
[42], the eﬀect of 30 min incubation in LK saline compared
to HK was determined in the presence of bromo-A23187
and diﬀerent [Ca2+]. LK saline was found to increase the
percentage of positive cells (Figure 6(a)), an eﬀect again par-
tially inhibited by clotrimazole (10 μM) which, for example,
reduced percentage of positive cells from 44% to 28% at
10 μM Ca2+. Finally, the eﬀect of the calmodulin inhibitor
W-7 was tested (Figure 6(b)). In this case, the percentage of
positive RBCs increased. It was noticeable, however, that in
all these manoeuvres, Ca2+ aﬃnity was unaﬀected (Figure 6).
4. Discussion
Whilst it is well known that RBCs from SCD patients show
elevated levels of PS exposure and that these are increased
upon deoxygenation, the mechanism is not clear. The present
results explore more fully that the role of Ca2+. Ca2+ concen-
trations required for scrambling is considerably lower than
previously appreciated. The Ca2+ aﬃnity of the scrambling
process is not dissimilar to that associated with inhibition
of flippase activity or activation of the Ca2+-activated K+
channel (Gardos channel). This important finding suggests
coordination of these eryptotic events. Results also implicate
a role for RBC shrinkage and shape change.
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Figure 5: Ca2+ loading of red blood cells (RBCs) from sickle cell
patients. RBCs were loaded with the Ca2+ fluorophore fluo-4 (see
Methods). They were then incubated for 30 min in the absence
(left—thin line) or presence (right—thick line) of bromo-A23187 at
an extracellular [Ca2+] of 1 μM. Results are presented as histogram
of fluorescence of a single experiment representative of 3.
4.1. Role of Ca2+ and Psickle on PS Exposure. Altering extracel-
lular Ca2+ levels had little eﬀect on PS exposure in oxygenated
HbS cells. Under deoxygenated conditions, however, PS
exposure increased with [Ca2+]o. This eﬀect was partially
inhibited by dipyridamole [40] and by intracellular Ca2+
chelation with MAPTAM treatment [34]. These findings are
consistent with Ca2+ entering via the deoxygenation-induced
pathway Psickle [4, 27] and acting intracellularly. Intracellular
Ca2+ can have several actions. First, it will activate the Gardos
channel leading to RBC shrinkage [43]. Second, it may
stimulate the Ca2+-dependent scramblase whilst inhibiting
the ATP-dependent flippase [14]. Third, it may stimulate
cysteine proteases [44]. Any of these events may lead to PS
exposure [21]. Several manoeuvres were tested to separate
these possibilities. The most eﬀective way of inhibiting PS
exposure was incubation in high K+ saline. Removal of
the electrochemical gradient for K+ eﬄux abolished the
deoxygenation-induced increase in PS exposure. The Gardos
channel inhibitor clotrimazole also partially inhibited PS
exposure. Findings are consistent with the hypothesis that
activation of Psickle, by deoxygenation mediates Ca
2+ entry,
elevating [Ca2+]i which then promotes PS exposure by
Gardos channel activation, loss of intracellular solutes, and
red cell shrinkage. Importantly, high K+ salines were eﬀective
over all incubation times (up to 18 hours). Shrinkage has
been shown previously to stimulate PS exposure in both
normal RBCs and HbS cells [37, 45] and would appear to
be involved in deoxygenation-induced PS exposure in sickle
cells.
4.2. Ca2+ Dependence of PS Exposure. A major aim of
this work was to determine unequivocally the intracellular
Ca2+ required to elicit PS exposure in HbS cells. This
was investigated using RBCs loaded with diﬀerent [Ca2+]s
using bromo-A23187. RBCs were first treated with vanadate
(to inhibit both the plasma membrane Ca2+ pump and
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Figure 6: Eﬀect of K+ and calmodulin inhibition on Ca2+-induced
exposure of phosphatidylserine (PS) in red blood cells (RBCs) from
sickle cell patients. Experimental details were as described in the
legend to Figure 4, except that in (a) where incubation was carried
out in either high K+-(HK, K+ = 90 mM) or low K+-containing
saline (LK, 4 mM), and, in (b) where HK saline was used in the
absence or presence of W-7 (100 μM). Results are presented as single
experiments representative of 3 others.
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the flippase) and subsequently with Co2+ (which blocks
A23187 so that the relatively high [Ca2+] required for
annexin binding, 2.5 mM, could not gain access to the
cytoplasm). Results showed that PS exposure was stimulated
by micromolar Ca2+ concentrations with an EC50 of about
1.2 μM. This concentration is similar, though slightly higher,
compared with that required for half-maximal activation of
the Gardos channel activation [46, 47] and for inhibition of
the flippase [26]. A similar high aﬃnity for Ca2+ was also
observed in RBCs incubated in LK saline indicating that
high K+ levels are not responsible for these observations.
Calmodulin is known to interact with RBC cytoskeleton
and influence PS exposure [48, 49]. Incubation with the
calmodulin antagonist W-7 again showed a similar high
Ca2+ aﬃnity for PS exposure. In this case, the percentage
of positive cells was also increased so that the majority of
RBCs became positive, showing that most RBCs are capable
of PS scrambling at these low Ca2+ levels. Previously reported
values for activation of the scramblase are considerably
higher than those given here, with values of 25–100 μM
quoted [14, 32]. Previous measurements, however, were
made largely on resealed RBC ghosts, inside-out vesicles, or
purified PLSCR1 [30, 31, 50, 51], which may not in fact
represent the RBC scramblase [52]. These preparations will
also necessarily lack much of the cytoplasmic contents which
may result in reduction in Ca2+ aﬃnity of the scrambling
process. Furthermore, several previous reports were carried
out in the presence of high concentrations of extracellular
Mg2+ (1 mM) [20, 30, 50], which with the ionophore A23187
would set intracellular Mg2+ at over 2 mM, considerably in
excess of the normal RBC [Mg2+] [53], and which might be
expected to dampen any Ca2+ driven process. We speculate
that having a similar Ca2+ level for Gardos channel activa-
tion, flippase inhibition and activation of scrambling would
coordinate eryptotic events [21] and facilitate removal dam-
aged RBCs in normal individuals, whilst in SCD patients,
hyperactivity of these processes may contribute to disease
pathogenesis.
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